Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteersREILLEY, Sandra; WENZEL, Eric; REYNOLDS, Laurie et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 3, pp 959-962, issn 0066-4804, 4 p.Article

Induction of Progressive Profound Hypocitraturia with Increasing Doses of Topiramate. Author's replyWARNER, Brad W; LAGRANGE, Chad A; TUCKER, Tarvez et al.Urology (Ridgewood, NJ). 2008, Vol 72, Num 1, pp 29-33, issn 0090-4295, 5 p.Article

Die Flabmethode zur intraoperativen Bestrahlung = The flab-method for intraoperative radiation therapyKNESCHAUREK, P; WEHRMANN, R; HUGO, C et al.Strahlentherapie und Onkologie. 1995, Vol 171, Num 2, pp 61-69, issn 0179-7158Article

Le tigason dans le psoriasis. Intérêt des doses progressivement croissantes = Tigason in psoriasis. Advantage of progressively increasing dosesDUBERTRET, L.Annales de dermatologie et de vénéréologie. 1985, Vol 112, Num 3, pp 289-290, issn 0151-9638Article

Acute exposure to methyl or ethyl alcohol alters auditory function in the ratWECKER, J. R; ISON, J. R.Toxicology and applied pharmacology. 1984, Vol 74, Num 2, pp 258-266, issn 0041-008XArticle

THE EFFECT OF ETHANOL ON HEPATIC SODIUM PLUS POTASSIUM ACTIVATED ADENOSINE TRIPHOSPHATASE ACTIVITY IN THE RATRICCI RL; CRAWFORD SS; MINER PB JR et al.1981; GASTROENTEROLOGY; ISSN 0016-5085; USA; DA. 1981; VOL. 80; NO 6; PP. 1445-1450; BIBL. 21 REF.Article

INFLUENCE DE LA FUMURE AZOTEE SUR LES RENDEMENTS ET LA QUALITE DU TABAC BURLEY S. 51CORBAZ R; HERREN P; JULMY L et al.1979; ANN. TABAC; FRA; DA. 1979-1980; NO 16; PP. 49-60; ABS. ENG/GER; BIBL. 6 REF.Article

COMPARATIVE EFFECTS OF MORPHINE AND NALORPHINE ON COLONIC MOTILITY IN THE CONSCIOUS DOGBUENO L; FIORAMONTI J; RUCKEBUSCH M et al.1981; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1981; VOL. 75; NO 4-5; PP. 239-245; BIBL. 21 REF.Article

Cancer chemotherapy 1973 - present : a personal perspectiveCARTER, S. K.Journal of cancer research and clinical oncology. 1995, Vol 121, Num 9-10, pp 501-504, issn 0171-5216Article

A dose-ranging of UK-87,798, a novel class III anti-arrhythmic agent, in normal volunteersGEMMILL, J. D; HOWIE, C. A; MEREDITH, P. A et al.British journal of clinical pharmacology. 1991, Vol 32, Num 4, pp 429-432, issn 0306-5251Article

Benefit of progressively increasing doses during the initial treatment with acitretin in psoriasisBERBIS, P; GEIGER, J.-M; VAISSE, C et al.Dermatologica. 1989, Vol 178, Num 2, pp 88-92, issn 0011-9075Article

Basophil histamine release remains unaffected by clinical desensitization to penicillinPIENKOWSKI, M. M; JAN KAZMIER, W; ADKINSON, N. F. JR et al.Journal of allergy and clinical immunology. 1988, Vol 82, Num 2, pp 171-178, issn 0091-6749Article

Escalating doses of sequential methotrexate and 5-fluorouracil, doxorubicin, and vincristine for the treatment of metastatic breast cancerSPITZER, T. R; GOLDSMITH, G. H. JR; LAZARUS, H. M et al.American journal of clinical oncology. 1987, Vol 10, Num 6, pp 483-484, issn 0277-3732Article

An ascending single-dose tolerance study of WY-45,030, a bicyclic antidepressant, in healthy menFABRE, L. F; PUTMAN, H. P. III.Current therapeutic research. 1987, Vol 42, Num 5, pp 901-909, issn 0011-393XArticle

A phase I trial of trans-1-diamino-cyclohexane oxalato-platinum (1-OHP)MATHE, G; KIDANI, Y; TRIANA, K et al.Biomedicine & pharmacotherapy. 1986, Vol 40, Num 10, pp 372-376, issn 0753-3322Article

Designing dose-escalation trials with late-onset toxicities using the time-to-event continual reassessment methodNORMOLLE, Daniel; LAWRENCE, Theodore.Journal of clinical oncology. 2006, Vol 24, Num 27, pp 4426-4433, issn 0732-183X, 8 p.Article

Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degenerationROSENFELD, Philip J; HEIER, Jeffrey S; HANTSBARGER, Gary et al.Ophthalmology (Rochester, MN). 2006, Vol 113, Num 4, pp 623-632, issn 0161-6420, 10 p.Article

Anesthesia with increasing doses of sufentanil and midlatency auditory evoked potentials in humansSCHWENDER, D; WENINGER, E; DAUNDERER, M et al.Anesthesia and analgesia. 1995, Vol 80, Num 3, pp 499-505, issn 0003-2999Article

Pharmacokinetic/dynamic assessment in drug development : application to the investigational opioid mirfentanilLEMMENS, H. J. M; EGAN, T. D; FISET, P et al.Anesthesia and analgesia. 1995, Vol 80, Num 6, pp 1206-1211, issn 0003-2999Article

Retrospective study of vigabatrin and psychiatric behavioural disturbancesWONG, I. C. K.Epilepsy research. 1995, Vol 21, Num 3, pp 227-230, issn 0920-1211Article

The effect of renal function on the pharmacokinetics of ranitidineDIXON, J. S; BORG-COSTANZI, J. M; LANGLEY, S. J et al.European journal of clinical pharmacology. 1994, Vol 46, Num 2, pp 167-171, issn 0031-6970Article

Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophreniaMARDER, S. R; WIRSHING, W. C; VAN PUTTEN, T et al.Archives of general psychiatry. 1994, Vol 51, Num 4, pp 280-287, issn 0003-990XArticle

Electrophysiologic and pharmacokinetic profile of the new antiarrhythmic drug TYB-3823 in humansCRIJNS, H. J. G. M; OOSTERHUIS, B; WIESFELD, A. C. P et al.Journal of cardiovascular pharmacology. 1993, Vol 21, Num 1, pp 1-6, issn 0160-2446Article

Cytosine arabinoside induced changes in natural killer and antibody dependent cellular cytotoxicity functions in multiple sclerosis patientsMOODY, D. J; FAHEY, J. L; DURKOS-SMITH, D et al.Journal of immunopharmacology. 1986, Vol 8, Num 2, pp 259-269, issn 0163-0571Article

Progressive dosages of clomiphene in hypothalamic anovulationGARCIA-FLORES, R. F; VAZQUEZ-MENDEZ, J.Fertility and sterility. 1984, Vol 42, Num 4, pp 543-547, issn 0015-0282Article